Trop2 deal heats up antibody–drug conjugate space in cancer

被引：0
|
作者：
Catherine Shaffer
机构：
来源：
Nature Biotechnology | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Gilead’s $21 billion gamble is a dramatic shot to secure a promising first-in-class oncology drug.
引用
收藏
页码：128 / 130
页数：2
相关论文
共 50 条
  • [1] Trop2 deal heats up antibody-drug conjugate space in cancer
    Shaffer, Catherine
    NATURE BIOTECHNOLOGY, 2021, 39 (02) : 128 - 130
  • [2] Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
    Zhao, Ming
    DiPeri, Timothy P. P.
    Raso, Maria Gabriela
    Zheng, Xiaofeng
    Rizvi, Yasmeen Qamar
    Evans, Kurt W. W.
    Yang, Fei
    Akcakanat, Argun
    Estecio, Marco Roberto
    Tripathy, Debu
    Dumbrava, Ecaterina E. E.
    Damodaran, Senthil
    Meric-Bernstam, Funda
    NPJ BREAST CANCER, 2023, 9 (01)
  • [3] Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
    Ming Zhao
    Timothy P. DiPeri
    Maria Gabriela Raso
    Xiaofeng Zheng
    Yasmeen Qamar Rizvi
    Kurt W. Evans
    Fei Yang
    Argun Akcakanat
    Marco Roberto Estecio
    Debu Tripathy
    Ecaterina E. Dumbrava
    Senthil Damodaran
    Funda Meric-Bernstam
    npj Breast Cancer, 9
  • [4] Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma
    McNamara, Blair
    Greenman, Michelle
    Bellone, Stefania
    Santin, Luca A.
    Demirkiran, Cem
    Mutlu, Levent
    Hartwich, Tobias Max Philipp
    Yang-Hartwich, Yang
    Ratner, Elena
    Schwartz, Peter E.
    Santin, Alessandro D.
    GYNECOLOGIC ONCOLOGY, 2024, 189 : 16 - 23
  • [5] Leveraging TROP2 Antibody-Drug Conjugates in Solid Tumors
    Nelson, Blessie Elizabeth
    Meric-Bernstam, Funda
    ANNUAL REVIEW OF MEDICINE, 2024, 75 : 31 - 48
  • [6] Clinical survey of Trop2 antibody drug conjugate target and payload biomarkers in multiple cancer indications using multiplex mass spectrometry
    Thyparambil, Sheeno P.
    Liao, Wei-Li
    Heaton, Robert
    Zhang, Guolin
    Strasbaugh, Amanda
    Melkie, Marya
    Ling, Xuefeng B.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Expression and co- expression patterns of TROP2 and HER2 in breast cancer: implications for bispecific antibody- drug conjugate therapy
    Onishi, Mai
    Shimoi, Tatsunori
    Kojima, Yuki
    Yazaki, Shu
    Yamanaka, Taro
    Kitadai, Rui
    Kawachi, Asuka
    Okuma, Hitomi
    Hoshino, Mai
    Saito, Ayumi
    Ito, Munehiro
    Maejima, Aiko
    Nishikawa, Tadaaki
    Sudo, Kazuki
    Noguchi, Emi
    Fujiwara, Yasuhiro
    Yoshida, Masayuki
    Yonemori, Kan
    CANCER RESEARCH, 2024, 84 (09)
  • [8] Preclinical activity of datopotamab deruxtecan, a novel trophoblast cell-surface antigen 2 (TROP2) directed antibody-drug conjugate targeting TROP2 in high grade serous ovarian carcinoma
    Mcnamara, Blair
    Greenman, Michelle
    Bellone, Stefania
    Demirkiran, Cem
    Mutlu, Levent
    Hartwich, Tobias
    Yang-Hartwich, Yang
    Ratner, Elena
    Schwartz, Peter
    Santin, Alessandro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A91 - A91
  • [9] Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models
    Meric-Bernstam, Funda
    Yuca, Erkan
    Evans, Kurt W.
    Zhao, Ming
    Maejima, Takanori
    Karibe, Tsuyoshi
    Raso, Maria Gabriela
    Tang, Ximing
    Zheng, Xiaofeng
    Rizvi, Yasmeen Qamar
    Akcakanat, Argun
    Scott, Stephen M.
    Wang, Bailiang
    Byers, Lauren A.
    Tripathy, Debu
    Okajima, Daisuke
    Damodaran, Senthil
    CLINICAL CANCER RESEARCH, 2025, 31 (03) : 573 - 587
  • [10] Quantitative Multiplex Immunofluorescence Assay for TROP2 and HER2 Expression in Breast Cancer: Towards Guiding Patient Selection for Antibody Drug Conjugate Therapies
    Robbins, Charles
    He, Mengni
    Khaimova, Revekka
    Bates, Katherine
    Chan, Nay Nwe Nyein
    Liebler, Daniel
    Fulton, Regan
    Rimm, David
    CANCER RESEARCH, 2024, 84 (09)
12345